Condition
Post Liver Transplant
Total Trials
4
Recruiting
0
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06304467Not ApplicableActive Not Recruiting
CM for Patients With ALD After Liver Transplant
NCT05063071Phase 4Unknown
Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant
NCT03386305Phase 2Active Not RecruitingPrimary
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
NCT01687270Phase 2Completed
Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant
Showing all 4 trials